Aspirin (ASA) to Prevent Colorectal Cancer - Frankly Speaking Ep 218

<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Credits: 0.25 AMA PRA Category 1 Credit™</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> CME/CE Information and Claim Credit: <a href= "https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-208" target="_blank" rel= "noopener">https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-218</a></p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Overview: Join us for this session where we will discuss the data behind the recent USPSTF recommendations on the use of ASA as a colorectal cancer (CRC) preventive agent, and when to incorporate this recommendation into practice.</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Episode resource links:</p> <ul> <li style="font-family: Calibri; font-size: 11pt;"><a href= "http://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer" target="_blank" rel= "noopener">www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer</a></li> <li style="font-family: Calibri; font-size: 11pt;"> doi:10.1001/jamaoncol.2020.7338</li> <li style="font-family: Calibri; font-size: 11pt;">N Engl J Med 2018; 379:1519-1528 DOI: 10.1056/NEJMoa1803955</li> </ul> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Guest: Robert A. Baldor MD, FAAFP</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Music Credit: Richard Onorato</p>